Reaction

Scedosporium Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 684 reports · 48 co-occurring drugs

As of the last recalculation, Scedosporium Infection appears in 684 FAERS reports alongside 48 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE INJECTION (PRR 304.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Voriconazole Injection	165	304.4	306.8
Posaconazole Delayed-Release	79	247.4	249.1
Voriconazole	172	229.9	231.2
Terbinafine Hydrochloride	61	229.3	230.9
Amphotericin B	77	210.6	211.9
Posaconazole	83	176.8	177.7
Basiliximab	52	145.5	146.2
Micafungin Sodium	34	128.4	128.9
Ganciclovir Sodium	37	112.4	112.8
Ganciclovir	35	109.6	110.0
Valganciclovir Hydrochloride Powder,	39	103.1	103.5
Tacrolimus Ointment 0.1%	259	101.2	101.5
Tacrolimus Extended-Release Capsules	259	101.0	101.2
Tacrolimus	275	88.7	88.8
Anti-Thymocyte Globulin (Rabbit)	21	81.7	81.9
Valganciclovir	45	77.7	77.9
Valganciclovir Hydrochloride	45	77.7	77.9
Itraconazole	27	73.2	73.4
Mycophenilic Acid	45	70.7	70.8
Meropenem	57	58.9	59.0
Mycophenolate Mofetil	165	48.4	48.5
Mycophenolate Mofetil Hydrochloride	165	48.3	48.4
Pegaspargase	18	45.9	46.0
Mycophenolic Acid	45	45.7	45.8
Sirolimus	17	39.4	39.4
Amikacin	21	38.6	38.7
Cefazolin	11	37.3	37.3
Fludarabine Phosphate	45	37.2	37.2
Mercaptopurine	17	30.6	30.6
Busulfan	15	29.6	29.7
Piperacillin And Tazobactam	12	29.0	29.1
Cefazolin Sodium	11	28.2	28.2
Piperacillin Sodium,Tazobactam Sodium	23	27.3	27.3
Cytarabine	50	27.2	27.3
Melphalan	17	23.3	23.3
Melphalan Hydrochloride	17	21.1	21.1
Tobramycin Solution	8	20.5	20.5
Tobramycin Sulfate	8	19.9	19.9
Linezolid	18	18.9	18.9
Azacitidine For	11	18.7	18.7
Ifosfamide	12	17.3	17.3
Cyclophosphamide Injection, Solution	88	17.2	17.2
Cyclophosphamide	88	17.2	17.2
Cyclophosphamide For Injection	88	17.2	17.2
Rifampin	8	16.9	16.9
Tobramycin	10	12.8	12.8
Azacitidine	12	12.5	12.5
Venetoclax	18	9.1	9.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.